ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 952

Effusion-Synovitis and Infrapatellar Fat Pad Edema Differentiate Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative

Julie Davis1, Robert J. Ward2, James MacKay3, Bing Lu4, Lori Lyn Price5,6, Timothy E. McAlindon7, Charles B. Eaton8, Mary Barbe9, Grace H. Lo10, Matthew Harkey1 and Jeffrey B. Driban11, 1Rheumatology, Tufts Medical Center, Boston, MA, 2Radiology, Tufts Medical Center, Boston, MA, 3Radiology, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 4Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 5Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, 6Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 7Division of Rheumatology, Tufts Medical Center, Boston, MA, 8Family Medicine and Community Health( Epidemiology), Alpert Medical School of Brown University, Pawtucket, RI, 9Temple University School of Medicine, Philadelphia, PA, 10Michael E. DeBakey Veterans Affairs Medical Center / Baylor College of Medicine, Houston, TX, 11Medicine, Division of Rheumatology, Tufts Medical Center, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Knee, Magnetic resonance imaging (MRI), osteoarthritis and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S105 ACR Abstract: Osteoarthritis–Clinical (952–957)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Accelerated knee osteoarthritis (AKOA) is a unique endotype of knee osteoarthritis (KOA) that is characterized by a sudden onset of advance-stage disease and greater prodromal knee symptoms than those who develop a more gradual onset of KOA. Effusion-synovitis and infrapatellar fat pad (IFP) edema, may be potential early markers of AKOA because both are associated with pain and predict KOA incidence or progression. We aimed to determine whether greater effusion-synovitis and IFP edema on MRI differentiate incident AKOA from a gradual onset of KOA or no KOA.

Methods: We classified 3 sex-matched groups of participants in the Osteoarthritis Initiative who had a knee without radiographic KOA at baseline (Kellgren-Lawrence [KL]<2; n=125/group): 1) AKOA: ≥1 knee progressed to KL grade ≥3 within 48 months, 2) common KOA: ≥1 knee increased in radiographic scoring within 48 months without meeting AKOA criteria, 3) no KOA: both knees had the same KL grade at baseline and 48-months. Observation period included up to 2 years before and after an index visit, which was when the AKOA or common KOA criteria were met (no KOA index visit was matched to AKOA). Two musculoskeletal radiologists reported presence of IFP edema using the MOAKS grading system. Independent readers used a semi-automated method to segment intermediate-weighted fat-suppressed MRIs for effusion-synovitis volume and measurements were finalized by the senior reader. We used generalized linear mixed models with group and time as independent variables, as well as tested a group-by-time interaction.

Results: Table 1 provides descriptive characteristics of each group. Starting at 2 years before disease onset and continuing to up to 2 years after onset, adults who developed AKOA had greater effusion-synovitis volume compared to adults with common or no KOA (p=0.015, p=0.003; Figure 1). Individuals who developed AKOA have at least two times the odds of having IFP edema compared to those with no KOA starting at 2 years prior to disease onset, and those with common KOA starting at 1 year prior to disease onset (Table 2, Figure 1).

Conclusion: As early as 2 years prior to disease onset AKOA is characterized by IFP edema and/or greater effusion-synovitis. Clinicians should be aware that people with greater effusion-synovitis and/or IFP edema in the absence of radiographic KOA may be at high risk for AKOA.

 

Table 1. Descriptive Characteristics of those with Accelerated Knee Osteoarthritis (AKOA), Common Knee Osteoarthritis (KOA), and No KOA at Osteoarthritis Initiative Baseline

Variables

(means, SD; except where noted)

AKOA

(n=125)

Common KOA

(n=125)

No

KOA

(n=125)

Females (n, %)

79 (63%)

79 (63%)

79 (63%)

Index knee KL Grade=0 (n, %)

42 (34%)

71 (57%)

92 (74%)

Patellofemoral Osteoarthritis (MR-based) (n, %)

88 (75%)

84 (69%)

80 (66%)

Frequent knee pain in past 12 months (n, %)

44 (35%)

49 (39%)

30 (24%)

Age (years)

62.5 (8.5)

58.4 (8.4)

57.3 (8.2)

Body mass index (kg/m2)

29.7 (4.6)

28.1 (4.4)

26.9 (4.4)

Global impact rating (0 to 10; higher score=greater impact)

1.7 (1.9)

1.1 (1.5)

0.8 (1.1)

How many days limited activities in past 30 days (0 to 30)?

3.2 (7.3)

1.7 (4.8)

1.4 (4.3)

WOMAC pain (0 to 20; higher score=more pain)

2.3 (3.1)

1.8 (2.3)

1.6 (2.4)

Notes: SD = standard deviation, KL = Kellgren-Lawrence, MR = magnetic resonance

 

Table 2. Adults with Accelerated Knee Osteoarthritis (AKOA) Have Twice the Odds of Having Infrapatellar Fat Pad Edema Than those with Common Knee Osteoarthritis (KOA), and No KOA (n = 125/group)

Outcome

Visit

 

 

 

Infrapatellar Fat Pad Edema (OR [95% CI])

AKOA vs

No KOA (REF)

Common KOA vs

No KOA (REF)

AKOA vs

Common KOA (REF)

-2

2.07 (1.14, 3.78)

1.67 (0.90, 3.08)

1.24 (0.69, 2.25)

-1

3.06 (1.71, 5.48)

1.46 (0.82, 2.60)

2.10 (1.19, 3.69)

Index

3.68 (2.07, 6.57)

1.18 (0.68, 2.06)

3.12 (1.79, 5.44)

1

3.66 (2.04, 6.57)

1.05 (0.60, 1.85)

3.48 (1.97, 6.16)

2

3.95 (2.09, 7.46)

1.06 (0.59, 1.92)

3.72 (2.01, 6.87)

Notes: OR=Odds Ratio. CI=Confidence Interval. REF= reference group. Group-by-time interaction: p<0.001). Infrapatellar fat pad edema was assessed on intermediate-weighted fat-suppressed magnetic resonance images.

A close up of text on a white background Description generated with very high confidence


Disclosure: J. Davis, None; R. J. Ward, None; J. MacKay, None; B. Lu, None; L. L. Price, None; T. E. McAlindon, None; C. B. Eaton, None; M. Barbe, None; G. H. Lo, None; M. Harkey, None; J. B. Driban, None.

To cite this abstract in AMA style:

Davis J, Ward RJ, MacKay J, Lu B, Price LL, McAlindon TE, Eaton CB, Barbe M, Lo GH, Harkey M, Driban JB. Effusion-Synovitis and Infrapatellar Fat Pad Edema Differentiate Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/effusion-synovitis-and-infrapatellar-fat-pad-edema-differentiate-accelerated-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effusion-synovitis-and-infrapatellar-fat-pad-edema-differentiate-accelerated-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology